This message was sent to ##Email##
|
|
|
|
|
EurekAlert!
Increased travel distance to a cancer treatment facility negatively impacts the likelihood that patients with stage II/III rectal cancer will receive radiation therapy (RT) to treat their disease, according to a study analyzing 26,845 patient records from the National Cancer Data Base that was published in the March 2016 issue of International Journal of Radiation Oncology Biology Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology. While travel burden was associated with receipt of RT, physician availability related to the geographic concentration of radiation oncologists was not.
READ MORE
Cure
The landscape of cancer care has been changing with the increased use of novel therapies. Targeted therapies and immunotherapies can be used as single agents or in combination with other therapies to treat a variety of cancers, including chronic lymphocytic leukemia (CLL), the most common leukemia in adults in the United States. Recently approved novel therapies for CLL include the immunotherapies Arzerra (ofatumumab) and Gazyva (obinutuzumab) and targeted agents Imbruvica (ibrutinib) and Zydelig (idelalisib). These therapies extend remission times and can also improve survival.
READ MORE
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
The 2016 Commission on Cancer (CoC) Annual Conference provides a comprehensive look at CoC standards and the National Cancer Data Base (NCDB) tools and resources. On June 1 and 2, CoC Program: Pathway to Quality Cancer Care focuses on the CoC Standards and the value of various roles on the cancer committee, guiding participants toward a first-rate quality cancer care program. The NCDB Workshop: Utilizing the NCDB for Quality Improvement on June 3 provides an in-depth look at the use of the NCDB tools, as well as best practices to maximize your cancer program's data. Developed by CoC and NCDB staff and committee leadership, these programs address a cancer program's common questions and concerns regarding CoC standards and compliance as well as the skills and knowledge needed to lead quality improvement initiatives using NCDB tools.
Medscape
Use of "dose-dense" adjuvant chemotherapy in premenopausal breast cancer patients is associated with a significant improvement in overall survival, according to new findings presented at the 10th European Breast Cancer Conference.
Adjuvant chemotherapy given every two weeks improved overall survival at 10 years by 29 percent in comparison with chemotherapy given at the standard interval of three weeks.
READ MORE
ACS
Many low- and middle-income countries do not have a defined medical specialty in surgical oncology and lack an educational infrastructure to respond to the local burden of cancer, but a Memorial Sloan Kettering Cancer Center (MSKCC) fellowship is succeeding in addressing this problem by training foreign medical graduates in surgical oncology. Results of the MSKCC oncology fellowship program are reported on in an "article in press" on the Journal of the American College of Surgeons website in advance of print publication later this year.
READ MORE
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
ACS
The Commission on Cancer is hosting a paper competition for physicians in training to foster the importance of oncology research in support of its mission. Papers are due June 30.
READ MORE
Centers for Disease Control and Prevention
Health literacy training is essential for anyone who works on health information with the intent to influence positive behavior changes. The CDC Health Literacy website has training materials produced by the CDC as well as references to reliable training sources outside the CDC. Visit our "Training from Organizations other than CDC" Web page to find online training on:
Health Literacy
Plain Language
Culture and Communication
Consumer and Patient Skill Building
Shared Decision-Making
Whether you are new to these topics, need a refresher or want to train others, you will find a variety of training options in the "Find Training" portion of our website.
READ MORE
CORDIS via Medical Xpress
EU researchers have made significant progress along the road to delivering novel drugs that improve life expectancy and the quality of life of pancreatic cancer patients. Following a systematic screening of natural and chemically synthesized compounds, the PANACREAS (integrating chemical approaches to treat pancreatic cancer: making new leads for a cure) project team has been able to identify a number of molecular targets that have shown promise in halting cancer progression.
READ MORE
May 13–14
Orlando, Florida
Join us May 13-14 at the B. Resort & Spa in Orlando for the NAPBC Best Practices Conference. This conference showcases successful processes and tools of NAPBC-accredited breast centers. Breast program leaders and care team members will share innovative and efficient methodologies that have been successfully implemented in accredited programs across the country. Attendees will receive tools for adoption of these best practices in their own centers.
Register today.
Cure
Building Blocks of Hope — Patient and Caregiver Strategies for LIVING with MDS is a free global print and online patient advocacy initiative that, through education, aims to foster feelings of comfort in those with the disorders and their caregivers.
The resource was developed in 2012 by Sandra Kurtin, an oncology nurse practitioner at the University of Arizona Cancer Center who is also an MDS Foundation Board member. Since then, it's been continually updated to reflect the ongoing changes in patient care and treatment.
READ MORE
|
|
 |
|
For the past 22 years, EduCare's mission has been to support Healthcare Professionals in educating breast cancer patients. We strive to offer products that are patient-friendly and up-to-date. Patient education increases compliance, reduces time constraints and promotes a partnership between patient and healthcare providers.
|
|
|
|
|
 |
|
Specialty Practice Management is a complete front- and back-office solution that offers a rapid return on your investment and improved satisfaction among your staff. Practices with 10 or fewer providers turn to this comprehensive solution to manage self-pay accounts and eliminate common mistakes.
|
|
|
|
mHealthIntelligence
A $14 device available at any electronics store may soon enable doctors to use their smartphones to diagnose skin cancers. Researchers at the University of Texas Health Science Center at Houston have reported using "smartphone microscopes" to diagnose non-melanoma skin cancers with about 90 percent accuracy and melanomas with about 60 percent accuracy. The technology platform offers advantages to clinicians who don't have access to high-powered microscopes but do have their smartphones.
READ MORE
Futurity
Scientists were surprised to find that drugs used to treat heart problems also have anticancer properties.
The drugs, called cardiac glycosides, cause the heart to contract and increase cardiac output. They are used in prescription medications such as Digitoxin and Strophanthin.
Now, researchers at Yale University have also discovered that cardiac glycosides block the repair of DNA in tumor cells.
READ MORE
Medical News Today
The unraveling of the human genome has triggered a shift toward classifying cancer according to patterns found in molecules and genes rather than cells and tissues. An example of this trend is a new study that defines a new subtype of bladder cancer that shares molecular signatures with some forms of breast cancer.
READ MORE
National Colorectal Cancer Roundtable
National Colorectal Cancer Awareness Month is the perfect opportunity to educate your community about the National Colon Rectal Roundtable's 80% by 2018 movement. More than 690 organizations have committed to eliminating colorectal cancer as a major public health problem and are working toward the shared goal of reaching 80% screened for colorectal cancer by 2018. Take this month to learn about the 80% by 2018 movement and be involved.
READ MORE
Cornell University via Medical Xpress
Cornell researchers from the Ithaca and Weill Cornell Medicine campuses have collaborated to develop an enzyme inhibitor that shows effectiveness against several types of cancer, most notably leukemia, breast cancer and colorectal cancer.
READ MORE
For additional information, please complete the mailing list request form.
|
|
|
Advertisement
Advertisement
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
